Skip to content
Screener

Rogers Corporation ROG Investing Cash Flow

Investing Cash Flow at other companies

3M logo
3MMMM
-$483M-790%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$255.52M-613%
Biogen logo
BiogenBIIB
-$3.84B-6,635%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$81.45M
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
-$102M+58.7%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0+100%

Other financials

Income statement

See full
Revenue$216.8M+6.9%
Gross profit$70.4M+10.0%
Operating income$20.0M+130%
Net income$13.6M+118%
EPS (diluted)$0.76+119%

Balance sheet

See full
Cash & equivalents$181.4M+15.4%
Total debt$28.5M-14.2%
Total equity$1.2B-0.2%
Total assets$1.4B-0.3%

Cash flow

See full
Operating cash flow$24.4M+78.1%
CapEx$6.1M-24.7%
Free cash flow$18.3M+227%

Valuation

See full
Market cap$2.39B+87.0%
Enterprise value$2.24B+93.9%
P/E89.5×
P/S2.9×+1.3×

Profitability

See full
Gross margin32.4%+0.2pp
Operating margin8.1%-6.7pp
Net margin3.2%+1.9pp
FCF margin9.9%+3.5pp

Returns & leverage

See full
Return on equity2.2%+1.3pp
Debt / equity0.0×
Current ratio+0.2×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Rogers Corporation’s 10-Q, filed July 29, 2026.

Filed
Jul 28, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000084748-26-000048
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Proceeds from the sale of property, plant and equipment, net13.4
Proceeds from the sale of marketable equity securities0.61.0
Purchases of short-term investments and marketable equity securities(30.1)(0.1)
Net cash used in investing activities(40.3)(3.4)
Financing Activities:
Payments of finance lease obligations(0.9)(0.8)
Payments of taxes related to net share settlement of equity awards(1.3)(1.4)
Proceeds from issuance of shares to employee stock purchase plan0.60.7

Item 1. Condensed Consolidated Financial Statements (Unaudited):

FAQ

What is Rogers Corporation's investing cash flow?
Rogers Corporation (ROG) reported investing cash flow of -$35.8M in Q2 2026.
How has Rogers Corporation's investing cash flow changed year-over-year?
Rogers Corporation's investing cash flow decreased by 390.4% year-over-year, from -$7.3M to -$35.8M.
What is the long-term trend for Rogers Corporation's investing cash flow?
Over 4 years (2021 to 2025), Rogers Corporation's investing cash flow has grown at a -50.1% compound annual growth rate (CAGR), from -$238.62M to -$14.8M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Rogers Corporation's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude